[Clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease] (Q74042198)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412529%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

review article

1 reference

title

[Clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412529%20AND%20SRC:MED&resulttype=core&format=json

chronic obstructive pulmonary disease

8 November 2019

main subject

1 reference

J A Barberà

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412529%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

G Peces-Barba

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412529%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A G Agustí

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412529%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J L Izquierdo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412529%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

E Monsó

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412529%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

T Montemayor

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412529%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J L Viejo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412529%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Sociedad Española de Neumología y Cirugía Torácica (SEPAR)

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412529%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412529%20AND%20SRC:MED&resulttype=core&format=json

Archivos de Bronconeumologia

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412529%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412529%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

297-316

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412529%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412529%20AND%20SRC:MED&resulttype=core&format=json

[Guidelines on the diagnosis and treatment of chronic obstructive lung disease. The SEPAR Working Group. The Spanish Society of Pneumology and Thoracic Surgery]

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

[Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Site and Nature of Airway Obstruction in Chronic Obstructive Lung Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

The relations between structural changes in small airways and pulmonary-function tests

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Alveolar inflammation and its relation to emphysema in smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

The interrelationship of sputum inflammatory markers in patients with chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Centrilobular and Panlobular Emphysema in Smokers: Two Distinct Morphologic and Functional Entities

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Exposure to biomass smoke and chronic airway disease in Mexican women. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

The natural history of chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

The relationship between pulmonary function and dyspnea in obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Psychophysical bases of perceived exertion

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Physician perceptions and management of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Improved exercise performance following lung volume reduction surgery for emphysema.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Breathing during sleep in patients with obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Do sleep studies contribute to the management of patients with severe chronic obstructive pulmonary disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Radiographic appearance of the chest in emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

The diagnosis of mild emphysema. Correlation of computed tomography and pathology scores

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Quality of life in patients with chronic airflow limitation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

[The Spanish translation and evaluation of a quality-of-life questionnaire in patients with chronic obstructive pulmonary disease]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

[Guidelines for the treatment of smoking. The Working Group for the Treatment of Smoking of the Smoking Area. SEPAR (Sociedad Española de Neumología y Cirugía Torácica)]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

1 reference

7 January 2021

[An evaluation of the bronchodilator response with beta agonists in patients with chronic obstructive pulmonary disease]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Should long-acting beta 2-agonists be considered an alternative first choice option for the treatment of stable COPD?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Efficacy of salmeterol xinafoate in the treatment of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Is theophylline obsolete?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Theophylline is no more obsolete than "two puffs qid" of current beta 2 agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Theophylline therapy. A continuing dilemma.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Theophylline and mucociliary clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Theophylline improves global cardiac function and reduces dyspnea in chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Use of theophylline in the treatment of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

[Inhaled corticoids in COPD]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

EUROSCOP, ISOLDE and the Copenhagen city lung study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

[The current state of substitution treatment in congenital emphysema due to alpha-1-antitrypsin deficiency. The report of the National Registry]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Clinical trials needed for alpha 1-antitrypsin replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Chronic respiratory failure in COPD: is there a place for a respiratory stimulant?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

[Respiratory rehabilitation]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

The long-term effects of pulmonary rehabilitation in patients with asthma and chronic obstructive pulmonary disease: a research synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Peripheral muscle weakness contributes to exercise limitation in COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Aerobic and strength training in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Respiratory muscle training in chronic airflow limitation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Inspiratory muscle training in chronic airflow limitation: comparison of two different training loads with a threshold device

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Nutritional support for individuals with COPD: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

A comparison between an outpatient hospital-based pulmonary rehabilitation program and a home-care pulmonary rehabilitation program in patients with COPD. A follow-up of 18 months

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Randomised controlled trial comparing hospital at home care with inpatient hospital care. II: cost minimisation analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

[Guidelines for indications and use of domiciliary continuous oxygen (DCO) therapy. SEPAR guidelines]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Pulmonary rehabilitation in chronic respiratory insufficiency. 6. Travel for technology-dependent patients with respiratory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

1 reference

7 January 2021

Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Long-term health status and quality of life outcomes of lung transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Lung volume reduction surgery. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, May 1996

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Rationale and design of The National Emphysema Treatment Trial: a prospective randomized trial of lung volume reduction surgery. The National Emphysema Treatment Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Effect of lung-volume-reduction surgery in patients with severe emphysema.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Lung volume reduction surgery for emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Lung function 4 years after lung volume reduction surgery for emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Lung volume reduction surgery: comparison of preoperative radiologic features and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Evaluation and preoperative management of lung volume reduction surgery candidates

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Reduction pneumoplasty for giant bullous emphysema. Implications for surgical treatment of nonbullous emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Functional evaluation of the lung resection candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Preoperative assessment as a predictor of mortality and morbidity after lung resection

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Invasive exercise testing in the evaluation of patients at high-risk for lung resection

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Early postoperative stress: video-assisted wedge resection/lobectomy vs conventional axillary thoracotomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Exercise capacity as a predictor of postoperative complications in lung resection candidates

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Association of indoor and outdoor particulate level with chronic respiratory illness

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

The UCLA population studies of chronic obstructive respiratory disease: XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Use of emergency medical services by patients with decompensated obstructive lung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

When can an exacerbation of COPD be treated at home?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Epidemiology and treatment of chronic bronchitis and its exacerbations.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Spirometric criteria for hospital admission of patients with acute exacerbation of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Oxygen therapy during exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Effects of the administration of O2 on ventilation and blood gases in patients with chronic obstructive pulmonary disease during acute respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2801%2975074-0

7 January 2021

10.1016/S0300-2896(01)75074-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412529%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference